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Tuberculosis (TB) is a communicable disease 
that afflicts 9 million people and claims 2 mil-
lion lives annually (WHO, 2008). The disease 
is caused by the intracellular pathogen Mycobac-
terium tuberculosis (MTB) which persists in rest-
ing macrophages. Protective immunity against 
TB  depends  on  robust  responses  of  type  1 
helper T (Th1) cells that achieve bacterial con-
tainment, but not sterile eradication (Flynn and 
Chan, 2001).
Once inhaled, MTB is recognized by pat-
tern recognition receptors (PRRs), which are 
nonclonally expressed by macrophages, DCs, 
or epithelial cells. After receptor engagement, 
PRRs transduce signals to adaptor molecules, 
which mobilize appropriate defense mecha-
nisms. To date, several key adaptor molecules 
have been characterized (Ishii et al., 2008): 
MyD88 collects signals from most Toll-like 
receptors (TLRs), TRIF primarily from TLR-
3/4, RIP2 from nucleotide-binding oligomer-
ization domain (NOD)–like receptors (NLRs, 
like NOD1 and 2), and the recently described 
caspase recruitment domain family, member 9 
(CARD9) from some TLRs, as well as from 
NOD2 and dectin-1 (Gross et al., 2006; Hara 
et al., 2007; Hsu et al., 2007). These adaptors 
can activate NF-B, MAPKK, or IRFs, and 
the master regulators for synthesis of cytokine 
and type I IFNs. MTB is a complex prokaryote 
consisting of myriads of structurally different 
molecules that can be recognized by different 
PRRs. Effects of single or multiple deletions of 
TLRs (TLR 2, 4 and 9; Reiling et al., 2002; 
Hölscher et al., 2008; Reiling et al., 2008)   
or NLRs (NOD2; Gandotra et al., 2007) on 
murine TB are minimal. Moreover, although 
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The cross talk between host and pathogen starts with recognition of bacterial signatures 
through pattern recognition receptors (PRRs), which mobilize downstream signaling cas-
cades. We investigated the role of the cytosolic adaptor caspase recruitment domain family, 
member 9 (CARD9) in tuberculosis. This adaptor was critical for full activation of innate 
immunity by converging signals downstream of multiple PRRs. Card9/ mice succumbed 
early after aerosol infection, with higher mycobacterial burden, pyogranulomatous pneu-
monia, accelerated granulocyte recruitment, and higher abundance of proinflammatory 
cytokines and granulocyte colony-stimulating factor (G-CSF) in serum and lung. Neutral-
ization of G-CSF and neutrophil depletion significantly prolonged survival, indicating that 
an exacerbated systemic inflammatory disease triggered lethality of Card9/ mice. CARD9 
deficiency had no apparent effect on T cell responses, but a marked impact on the hemato-
poietic compartment. Card9/ granulocytes failed to produce IL-10 after Mycobaterium 
tuberculosis infection, suggesting that an absent antiinflammatory feedback loop ac-
counted for granulocyte-dominated pathology, uncontrolled bacterial replication, and, 
ultimately, death of infected Card9/ mice. Our data provide evidence that deregulated 
innate responses trigger excessive lung inflammation and demonstrate a pivotal role of 
CARD9 signaling in autonomous innate host defense against tuberculosis.
© 2010 Dorhoi et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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disorganized with multiple necrotic foci and lacked typical 
granulomatous appearance. Large infiltrates were often sur-
rounded by emphysematous tissue and rarely by functional 
alveoli. Spleen pathology did not significantly differ between 
mouse strains (Fig. S2). Because the lung architecture was mas-
sively altered, we assessed impact of Card9 deficiency on cell 
death. iNOS expression was determined as a major antimi-
crobial effector molecule in mice. In accordance with the results 
obtained for NO serum levels (Fig. S2), iNOS immunostain-
ing revealed no apparent differences between WT and KO 
animals. The more intense TUNEL signals in the Card9/ 
mice indicated differential apoptotic cell death. We also de-
tected a different TUNEL staining pattern. In WT tissues, 
apoptotic signals were nuclear, whereas extracellular, intersti-
tial  TUNEL-positive  material  preponderated  in  Card9/ 
lungs, indicative of secondary necrosis. Thus, increased cell death 
events in inflamed lungs of Card9/ mice correlated with 
TB susceptibility.
Defective responses to MTB infection in Card9/ antigen-
presenting cells
To define the mechanisms responsible for the high suscepti-
bility to TB in Card9/ mice, we generated BM-derived 
macrophages  (BMDMs)  and  BM-derived  DCs  (BMDCs) 
and infected them with MTB H37Rv. Card9/ BMDMs 
produced similar NO levels as WT cells (Fig. 2 C), and were 
neither impaired in internalization (Fig. 2 B) nor in killing of 
MTB after IFN- activation (Fig. 2 A). Strong evidence for 
increased cell death in lungs of Card9/ mice prompted us 
to determine whether deficient BMDMs showed accelerated 
cell death after MTB encounter. Nucleosome enrichment in 
postnuclear fractions did not differ, suggesting similar fre-
quencies of apoptotic cell death in WT and KO cells after 
MTB infection (Fig. 2 D). Clearance of apoptotic cells by 
Card9/ BMDMs was also not impaired (Fig. S3).
To monitor cell activation status we measured cytokine 
levels in culture supernatants. Card9/ BMDMs were im-
paired in synthesis of the proinflammatory cytokines TNF, 
IL-6, and CCL5 and produced less IL-12 compared with 
WT cells (Fig. 2 E). Moreover, they were defective in IL-1 
release (Fig. 2 F). A similar response pattern of infected BM-
DCs  (depicted  for  IL-1  and  TNF)  and  lower  IL-12p40 
abundance was recorded (Fig. S4). We hesitate to draw con-
clusions on the biological meaning of IL-12 levels in DC su-
pernatants because of the high background caused by MACS 
separation of the cells. However, we do assume that CARD9 
is critical for adequate activation of innate immune cells after 
MTB recognition.
CARD9 as central adaptor in MTB recognition
CARD9 is involved in multiple signaling pathways, down-
stream of different classes of PRRs (Ishii et al., 2008). To 
characterize receptors upstream of CARD9 involved in APC 
responses to MTB, we performed experiments using heat-
killed MTB or blocking phagocytosis. The differential acti-
vation after cytochalasin treatment or after recognition of 
TLR-2 and NOD2 are nonredundant receptors for MTB 
recognition in vitro (Ferwerda et al., 2005), double KO mice 
for these receptors control lung infection efficiently (Gandotra 
et al., 2007). Yet, animals deficient in the MyD88–IL-1R 
pathway fail to control TB (Fremond et al., 2004, 2007). 
Consistent with these observations and considering the struc-
tural diversity of the mycobacterial cell wall, “adaptor check 
points” rather than “receptor check points” are essential for 
control of MTB in innate immune cells.
PRRs  involved  in  MTB  recognition  not  only  use 
MyD88-dependent, but also MyD88-independent pathways 
(Shi et al., 2003; Fortune et al., 2004; Schnappinger et al., 
2006), and therefore additional adaptors await identification. 
The involvement of the adaptor CARD9 was recently re-
ported in early recognition and defense against Candida sp. 
(Gross  et  al.,  2006)  and  Listeria  monocytogenes  (Hsu  et  al., 
2007). It samples signals from diverse classes of receptors, 
such as C-type lectin receptors (CLRs) and other ITAM-
based receptors, RIG-I–like helicases (Poeck et al., 2010), 
NLRs, and TLRs (Hara et al., 2007), and can act indepen-
dently of MyD88. Here, we investigated whether CARD9 is 
involved in control of TB.
In the mouse model of pulmonary TB we demonstrate a 
crucial role of CARD9 in control of MTB. We provide 
compelling evidence for a critical role of CARD9 as a central 
adaptor downstream of multiple receptors involved in MTB 
recognition. Absence of CARD9 resulted in a lethal systemic 
inflammatory disease dominated by augmented cell death in 
the lung and marked neutrophil pathology. In contrast, T cell 
responses were apparently not affected by this deficiency. 
Survival of Card9/ mice was prolonged by granulocyte 
colony-stimulating factor (G-CSF) neutralization or granulo-
cyte depletion. Similar effects were achieved after MTB cur-
tailment by antibiotic treatment before or after the neutrophilic 
response had been initiated. Failure to control inflammation 
in KO mice was linked to abolished secretion of IL-10 in 
MTB-infected Card9/ granulocytes and inability to dampen 
inflammation. We propose a central role for CARD9 in con-
trol of TB and assume that Card9 deficiency causes aberrant 
systemic inflammation culminating in lethal lung damage.
RESULTS
Fatal tuberculosis in Card9/ mice
Aerosol infection with virulent strain MTB H37Rv caused 
rapid death of Card9/ mice (Fig. 1 A). Diseased animals 
gradually lost weight (Fig. S1) and started to succumb at 26 d 
post infection (p.i.). Over a wide range of the bacterial inoc-
ulum (100–450 CFUs) we observed a remarkable susceptibil-
ity of Card9/ mice, which did not survive beyond 34 d p.i. 
in any of the experimental settings.
Lung bacterial burdens were significantly higher in Card9/ 
mice (Fig. 1 B), and Ziehl-Neelsen staining of infected lungs 
confirmed CFU results (Fig. 1 C). Histological examination 
revealed profound tissue damage in susceptible animals (Fig. 1, 
D–F), characterized by acute pneumonia with accelerated 
accumulation of inflammatory cells. Parenchyma appeared JEM VOL. 207, April 12, 2010 
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Because the relevance of TLRs in TB is well established 
(Reiling et al., 2008), we focused on dectin-1/Syk–dependent 
macrophage activation by MTB. We treated cells with either 
500 µg/ml laminarin or 1–10 µM piceatannol 1 h before 
heat-killed MTB confirmed our experiments with live MTB 
(Fig. 3 A). We conclude that the CARD9 pathway is impor-
tant for sensing MTB lipoglycan compounds through cell 
surface PRRs.
Figure 1.  Card9/ mice fail to control pulmonary tuberculosis. (A) Survival of WT and Card9/ mice (n = 15) after aerosol infection with virulent 
MTB H37Rv (450 CFUs), Kaplan-Meier curves, and log-rank test. (B) Bacterial burdens in lungs and spleens of infected animals (n = 5). Data from one of 
four experiments, Mann-Whitney test for statistic analysis. (C) Ziehl-Neelsen staining of acid fast bacilli in lungs of infected mice. (D–F) Histopathology of 
lungs; Giemsa staining (D) of paraffin-embedded tissue showed acute pneumonia with multiple necrotic foci in susceptible mice; immunostaining for 
iNOS did not reveal major differences (E); TUNEL staining revealed accelerated cell death in Card9/ mice (F). TUNEL-TMred and nuclei are DAPI stained. 
Tissue were collected at 28 d p.i. Data in C–F are representative of two independent experiments (n = 5). Bars: (C) 20 µm; (D) 2.5 mm; (E) 200 µm;  
(F) 100 µm. **, P < 0.01.780 CARD9 in control of mycobacterial infection | Dorhoi et al.
Figure 2.  Card9/ BMDMs control MTB despite impaired cytokine synthesis. (A) BMDMs from WT and Card9/ mice were infected with MTB 
H37Rv at MOI 5 and bacterial multiplication was assed by [3H]Uracil incorporation. (B) WT and Card9/ BMDMs were infected with gfp-BCG at different 
MOI and mycobacterial uptake was monitored by FACS analysis of the F4/80+ population, insert lower MOI (0.4 and 2) were assessed as well. (C) Card9/ 
BMDMs were not hampered in NO release, NO in cell culture supernatants was assessed by Griess reaction. (D) Cell death after MTB infection was evalu-
ated by nucleosome enrichment in the post-nuclear fraction using ELISA. (E) Cytokines in supernatants of infected cell were determined by ELISA. Data 
are mean ± SEM of two experiments with six replicates each (A) or are representative of three independent experiments with three replicates each (B–E). 
**, P < 0.01; ***, P < 0.001, Student’s t test.
infection. Both laminarin (-glucan, thus blocking dectin-1) 
and  piceatanol  (syk  inhibitor)  specifically  blocked  TNF 
and IL-6 synthesis, leaving MTB internalization unaffected 
(Fig. S5 A). Thus, dectin-1 signaling was involved in proin-
flammatory  responses  against  MTB  (Fig.  3  B).  Next,  we 
stimulated BMDMs and DCs with the following MTB-
derived molecules: peptidoglycan (PG), mycolyl-arabinoga-
lactan (AG) PG (mAGP), manLam, and trehalose dimycolate 
(TDM). We measured levels of TNF, IL-10 (Fig. 3 C), IL-12, 
and IL-6 24 h after stimulation. Scant cell activation was JEM VOL. 207, April 12, 2010 
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Systemic inflammatory disease in absence of CARD9 despite 
apparently normal T cell responses
To further characterize the role of CARD9 in TB in vivo, 
we performed a detailed analysis of innate and adaptive cell 
responses in the lungs and spleens of infected mice. Aerosol 
infection with a low inoculum (70 CFUs) did not reveal ap-
parent differences in T cell subpopulations recruited to the 
lung at day 14 p.i. Disease progression did not alter the ratio 
of CD4+/CD8+ cells in Card9/ versus WT mice (Fig. 4 A). 
Moreover, the frequencies of PepA tetramer-positive CD8+ 
T cells (Fig. 4 B) and FoxP3+ T lymphocytes (unpublished 
data) did not differ in Card9/ and WT mice. Next, we de-
termined T cell functions. Cytokine production (IL-2, IFN-
, TNF, and IL-17) was not altered consistently (Fig. 4 B and 
Fig. S6). Moreover, in preliminary experiments CARD9 KO 
observed for manLam and TDM (unpublished data). This 
observation  is  in  agreement  with  studies  that  investigated 
TDM/TDB activity on myeloid cells and reported minimal 
cytokine release at 24 h, but substantial production at later 
timepoints (Werninghaus et al., 2009). Clear differences 
were measured for mAGP (Fig. 3 C and Fig. S5, B and C). 
The  mAGP-triggered  cytokine  synthesis  in  macrophages 
depends on NOD2, an intracellular sensor for PG (Fortune   
et al., 2004; Gandotra et al., 2007). Mycolic acid methyl   
esters (MAMEs) and AG, which are constituents of mAGP, 
induced scant TNF release (unpublished data). Overall, our 
data suggest that the CARD9 adaptor collects signals from 
various  PRRs,  including  dectin-1,  and  NOD2  during   
MTB infection, reemphasizing its critical role in control of 
innate immunity.
Figure 3.  The adaptor molecule CARD9 converges signals from multiple PRRs involved in MTB recognition. (A) Deficient inflammatory cytokine 
production by Card9/ BMDMs in response to heat-killed MTB or after blocking of phagocytosis. (B) Blocking dectin-1–syk pathway in WT cells recapitu-
lated the observations reported for Card9/ BMDMs, as revealed by selective impairment of TNF and IL-6 production. (C) mAGP induced diminished cy-
tokine levels in Card9/ macrophages. Data are mean ± SEM of two independent experiments with three replicates each. *, P < 0.05; **, P < 0.01; ***, P < 
0.001, Student’s t test.782 CARD9 in control of mycobacterial infection | Dorhoi et al.
The Card9 deficiency caused marked accumulation of 
neutrophils in the lungs of infected mice (Fig. 5 A). The 
frequency of DCs and lung macrophages, as well as the ex-
pression level of a maturation marker expressed by APC 
(CD86), in infected lungs did not differ between the mouse 
strains  (Fig.  5  B).  Yet,  myeloperoxidase  (MPO)  staining 
and WT mice mounted similar delayed-type hypersensitivity 
(DTH) responses and protective immunity in response to BCG 
vaccination (Fig. 4, C and D). Thus, vaccination-induced ac-
quired immunity overcame CARD9-dependent innate im-
mune deficiency. We conclude that CARD9 defects affect 
innate immune rather then acquired T cell responses in TB.
Figure 4.  Card9/ mice develop efficient T cell responses to mycobacterial infections. (A) Lymphocyte percentages were similar in MTB-infected 
Card9/ and WT mice at 14 and 28 d p.i. as shown by FACS analysis of CD4+ and CD8+ lung T cell populations. (B) Card9/ mice mounted normal lung T 
cell responses, as revealed by frequencies of MTB-specific PepA tetramer+ (GAPINSATAM) CD8+ T cells and IFN-/IL-2+ CD4+ or CD8+ T cells. Data are rep-
resentative of two independent experiments (n = 5). Two-way ANOVA and Bonferroni method were applied for statistical analyses. (C) WT and Card9/ 
mice develop similar DTH responses 3 wk after BCG vaccination (n = 12). (D) Survival of Card9/ mice challenged with 200 CFUs of MTB H37Rv is signifi-
cantly prolonged by BCG vaccination (n = 10). Data shown is from one experiment (C and D).JEM VOL. 207, April 12, 2010 
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demonstrated  that  granulocytes  accumulated  in  nest-like 
structures within large inflammatory foci (Fig. 5 G). The 
accelerated lung recruitment of polymorphonuclear neu-
trophils (PMNs) was paralleled by aggravated disease, sug-
gesting a critical role of neutrophils in disease progression to 
fatal outcome.
Figure 5.  Susceptibility of Card9/ mice to tuberculosis is caused by increased granulopoiesis and accelerated neutrophil recruitment to in-
flamed lungs. (A) Neutrophil accumulation in lungs during TB in Card9/ mice and (B) expression of the costimulatory molecule CD86 on surface of lung DCs 
and macrophages. (C and D) Analysis of cytokine and chemokine concentrations in lung homogenates and sera revealed that Card9/ mice developed systemic 
inflammatory responses with increased local proinflammatory cytokines and high levels of soluble mediators of granulocyte development and chemotaxis at 
day 14 p.i. (C) and day 24 p.i. (D). (E) Increased serum levels of granulocyte MPO in Card9/ mice. (F) Up-regulation of PMN-related genes in lung of infected 
mice 14 d p.i. (G) Card9/ mice presented multiple clusters of MPO+ granulocytes within large inflammatory lung infiltrates. Bar, 100 µm. Data are representa-
tive of two independent experiments (n = 5). Two-way ANOVA and Bonferroni method were applied for statistical analyses. **, P < 0.01; ***, P < 0.001.784 CARD9 in control of mycobacterial infection | Dorhoi et al.
We attempted to define triggers of neutrophilic inflam-
mation during MTB infection and to verify the relevance of 
disbalanced cytokine responses as observed in vitro. To this 
end, we determined chemokine and cytokine concentrations 
in lung homogenates and serum. 2 wk p.i., we barely de-
tected any differences (Fig. 5 C), but obvious changes ap-
peared by 3 wk p.i. (Fig. 5 D). CCL5 concentration was 
reduced in the lungs of Card9/ mice. This deficiency alone 
could not explain the heightened lethality of Card9/ ani-
mals to TB because CCR5 has multiple ligands (including 
MIP-1 and MIP-1) and there is substantial redundancy 
in the chemokine system (Algood and Flynn, 2004; Badewa 
et al., 2005). Strikingly, MCP-1 and cytokines involved in 
neutrophil differentiation (G-CSF) and recruitment (keritino-
cyte-derived chemokine [KC]) were markedly elevated in 
susceptible mice. Moreover, we detected increased concen-
trations of granulocyte-derived MPO in sera of Card9/ 
mice (Fig. 5 E). In absence of CARD9, PMN transcriptional 
responses were detected as early as 14 d p.i., at a time-point 
where bacterial burdens did not differ (Fig. 5 F). Thus, we 
consider  systemic  inflammatory  disease  followed  by  tissue 
damage a result of augmented granulocyte differentiation in 
the BM by G-CSF and accelerated recruitment of these neu-
trophils to the lung by KC.
We interrogated whether adaptor deficiency in hemato-
poietic cells was the primary cause of uncontrolled inflamma-
tion and lethality. We generated Card9//WT bone-marrow 
chimera  mice  and  challenged  them  with  virulent  MTB. 
Transfer of CARD9 KO cells into irradiated WT mice ren-
dered recipients susceptible to TB, demonstrating a critical 
role of hematopoietic rather than radio-resistant cells in con-
trol of TB in absence of CARD9 (Fig. 6 A). Because of in-
creased PMN recruitment to lungs of Card9/ mice we 
compared expression of CARD9 in PMN versus other my-
eloid cells and alveolar epithelial cells (AECs). PMN abun-
dantly expressed CARD9 transcripts in steady-state, whereas 
BMDCs and lung macrophages were similar in terms of adap-
tor transcriptional activity (Fig. 6 B). AECs showed negligible 
Figure 6.  Susceptibility of Card9/ mice to tuberculosis resides in the hematopoietic compartment and is linked to Card9/ PMN defi-
ciencies to produce both pro- and antiinflammatory cytokines during TB infection. (A) BM chimeras were infected with 200 CFUs of MTB H37Rv 
and survival was followed up for 65 d p.i. (n = 8–10). (B) CARD9 expression in myeloid cells and AECs. (C) PMN from WT and Card9/ mice were infected 
with MTB H37Rv at MOI 5 and bacterial multiplication assed by [3H]Uracil incorporation. TNF (D) and IL-10 (E) levels in supernatants of MTB-infected 
PMN, determined by ELISA (MOI 5). Data are mean ± SEM of two experiments with six replicates each (C) or are representative of four independent ex-
periments with three to six replicates each (D and E). *, P < 0.05; **, P < 0.01; ***, P < 0.001, Student’s t test.JEM VOL. 207, April 12, 2010 
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Both neutrophilic inflammation and MTB replication render 
Card9/ mice susceptible to TB
To further assess whether neutrophilic hyperreactivity and 
subsequent tissue damage accounted for lethality of MTB in-
fected Card9/ mice, we designed rescue experiments. Two 
different strategies were followed. First, we used the cholesterol-
lowering agent lovastatin to accelerate removal of apoptotic 
transcriptional activity. After MTB encounter, CARD9/ 
PMN released less TNF compared with WT controls, but 
apparently  did  not  support  mycobacterial  growth  (Fig.  6,   
C and D). PMN isolated from KO mice had lost their pro-
pensity to secrete IL-10 when challenged with MTB (Fig. 6 E). 
We conclude that CARD9-deficient animals fail to fine-tune 
lung inflammation by means of IL-10.
Figure 7.  Neutrophil depletion ameliorates lung inflammation and prolongs survival. (A) Neutrophil depletion or G-CSF neutralization resulted in 
increased survival of MTB-infected Card9/ mice, Kaplan-Meier curves, and log-rank test. (B) Giemsa staining of infected lungs 24 d p.i. showed that 
granulocyte depletion ameliorated lung inflammation. (C) PMN depletion limited parenchyma infiltration with MPO+ cells. (D) PMN depletion reduced 
circulating levels of MPO and (E) PMN numbers (n = 4–6). Data are representative of one (G-CSF) or two (Gr-1) independent experiments (n = 5–10;  
24 and 21 d p.i., respectively). Two-way ANOVA and Bonferroni method were applied for statistical analyses. Bars: (B) 2.5 mm; (C) 100 µm. **, P < 0.01;  
***, P < 0.001.786 CARD9 in control of mycobacterial infection | Dorhoi et al.
liminary experiments, we used the first-line TB drugs isoniazid 
(INH) and rifampicin (RIF) to reduce bacterial burden 
(Fig. 8, A–C). Despite diminished susceptibility, there were 
30% death cases during the first 10 d when chemotherapy 
was started 3 wk p.i. (Fig. 8 A). When drug treatment started 
2 wk p.i., however, KO animals controlled TB infection 
(Fig. 8 D). MTB burdens in lung at the end of antibiotic 
treatment and 2 wk thereafter were more affected by INH/
RIF in Card9/ compared with WT mice (Fig. 8 E). We 
assume that reduced immune pressure in absence of CARD9 
allowed for more metabolically active, replicating MTB with 
higher susceptibility to drug treatment. Collectively, mecha-
nisms that fine-tune host inflammation and those controlling 
bacterial replication are both needed to overcome suscepti-
bility to TB in the absence of CARD9.
DISCUSSION
The first events after MTB has reached the alveolar space of 
the host lung include its recognition by alveolar macrophages 
via PRRs. They recruit adaptor molecules that transduce 
cells in the lung (Morimoto et al., 2006). Impaired removal 
of apoptotic cells causes secondary necrosis, thus triggering 
tissue damage (Kono and Rock, 2008). Second, we modu-
lated inflammatory responses by either neutralizing G-CSF 
or  depleting  PMNs  with  anti  Gr-1  monoclonal  antibody 
(mAb). Treatment with lovastatin did not improve survival. 
In contrast, granulocyte-limiting approaches prolonged sur-
vival of MTB-infected Card9/ mice (Fig. 7 A). Although 
bacterial burdens were not significantly altered after treat-
ment at 21 (G-CSF neutralization, preliminary data) or 25 d 
p.i. (PMN depletion; Fig. S7), survival was prolonged and 
accompanied by ameliorated lung inflammation, in 60–70% 
of the treated animals, and fewer MPO-positive cells were 
recruited to the lungs (Fig. 7, B and C). Remarkably, both 
treatments reduced circulating levels of MPO and granulo-
cytes (Fig. 7, D and E). Thus, limiting granulocyte infiltration 
of the lung dampened inflammation and prolonged survival of 
susceptible mice.
Next, we interrogated whether uncontrolled inflamma-
tion could be brought to an end by anti-TB therapy. In pre-
Figure 8.  TB chemotherapy prolongs survival of Card9/ mice. (A) Survival of mice infected with 400 CFUs MTB H37Rv and treated with INH/RIF 
(AB) at 3 wk p.i. Lung bacterial burdens (B) and serum G-CSF levels (C) at AB begin. (D) Survival of mice infected with 400 CFUs MTB H37Rv and treated 
with AB at 2 wk p.i. (E) MTB burdens in lungs and spleens of WT and KO mice before and after AB treatment. Data from one (A–C; n = 15) or two experi-
ments (D and E; n = 15). Mann-Whitney test was applied for statistical analyses, for survival Kaplan-Meier curves were used. *, P < 0.05; ***, P < 0.001.JEM VOL. 207, April 12, 2010 
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mice (Fig. S8). Thus, increased susceptibility of Card9/ 
mice was not caused by defective production of these antimi-
crobial effector molecules. Yet, CARD9 was required for an 
efficient innate activation program in vitro and for antimyco-
bacterial immune homeostasis in vivo. We observed reduced 
cytokine synthesis by KO cells after MTB encounter. Re-
duced TNF production could explain defective granuloma 
formation, at least in part (Bean et al., 1999; Chakravarty et al., 
2008). Diminished IL-12 synthesis by macrophages was re-
produced in DCs, but could not be detected in infected tis-
sue. Because of similar lung levels of IL-12, critical for Th 
cell polarization (Khader et al., 2006), apparently unrestrained 
Th1 responses could develop in absence of CARD9 signaling 
during TB. Card9/ mice suffered from higher bacterial ti-
ters as early as 3 wk p.i. In parallel, the animals exhibited 
pyogranulomatous infiltrates rich in neutrophils in the lung, 
increased death, and impaired removal of dead cells from the 
lung parenchyma. Fatal disease progression in the absence of 
CARD9 signaling was thus accompanied by exacerbated in-
flammation induced by granulocytes.
The relevance of PRRs for initiating and shaping adap-
tive immunity is beyond doubt (Medzhitov, 2007; Dorhoi 
and Kaufmann, 2009). Strikingly, absent CARD9 signaling 
did not seem to affect T cell responses to MTB, suggesting it 
is dispensable for development of appropriate T cell responses 
in TB. Card9/ mice developed normal Th1 responses to 
MTB in vivo despite reduced IL-12 production by APC in 
vitro. Moreover, we did not detect any deficiency in Th17 
response  to MTB, although involvement of the syk-CARD9 
pathway in differentiation of IL-17-producing CD4+ T cells 
has  been  described  (LeibundGut-Landmann  et  al.,  2007). 
Neutrophil-mediated defense against C. albicans induced by 
efficient Th17 responses is CARD9 dependent. Mycobacte-
ria are decorated with various pathogen-associated molecular 
patterns that trigger multiple PRRs simultaneously, whereas 
C. albicans is rich in -glucans, which are sensed by CLRs. 
Simultaneous engagement of an array of PRRs likely has a 
different outcome (Seimon et al., 2006; Trinchieri and Sher, 
2007). Hence, multiple receptor recognition of MTB cannot 
be mimicked by single receptor–ligand interactions, such as 
synthetic TDM derivatives. Our Th17 data during MTB in-
fection are consistent with a recent study by Werninghaus et al. 
(2009), although the two studies investigated different tis-
sue sites. The differences in IFN- producers in the lung 
tissue was not confirmed in our study, although overall lung 
IFN- abundance did not differ (Fig. 5, C and D). Notably, 
both studies point to efficient T cell activation in absence of 
CARD9. Strikingly, despite using a similar dose of MTB 
laboratory strain, the CARD9 KO animals survived longer in 
this study (Werninghaus et al., 2009). This could be explained 
by differential virulence of the MTB stocks used. In any case 
intact T cell immunity failed to overcome the severe innate 
defects of Card9/ mice in MTB infection. On the contrary, 
protective T cell responses were efficiently stimulated by BCG 
vaccination. CARD9 KO mice not only developed DTH, 
but also protection against MTB. We conclude that in the 
signals culminating in transcriptional responses that deter-
mine the type of the ensuing immune response. The adaptor 
molecule CARD9 is expressed in myeloid cells (Bertin et al., 
2000) and in lung tissue (Hsu et al., 2007). Here, we demon-
strate that: (a) CARD9 adaptor was central for sampling of 
signals from various PRRs involved in MTB recognition; (b) 
CARD9 was essential for control of pulmonary TB; (c) un-
controlled MTB replication and excessive lung inflammation 
resulted in lethal outcome of MTB infection in Card9/ 
mice. We conclude that CARD9-dependent tight control of, 
and by, PMN are essential for innate immunity in TB. Our data 
thus emphasize the double-edged role of innate immunity in 
protection and pathology in TB.
Disruption  of  TLRs  impairs  long-term  control  of  TB 
(Hölscher et al., 2008) and deficiencies in IL-1R (Fremond 
et al., 2007), MyD88 (Fremond et al., 2004), or TIR8 (Garlanda 
et al., 2007) result in fatal acute TB disease. Animals devoid 
of TIR8, a negative regulator of TLR signaling, or D6, a de-
coy and scavenger receptor for inflammatory CC chemokines, 
suffer  from  uncontrolled  systemic  inflammation,  although 
they normally control bacterial replication (Garlanda et al., 
2007; Di Liberto et al., 2008). These findings indicate that 
control of both bacterial growth and inflammation are decisive 
determinants of disease outcome. MTB-infected Card9/ 
mice suffered concomitantly from higher MTB burdens in 
lungs and a systemic inflammatory response associated with 
profound lung pathology. Pyogenic pneumonia in Card9/ 
mice resembled lesions observed in MTB-infected MyD88 
and IL-1R KO mice (Fremond et al., 2004, 2007) or mice 
deficient for Ipr1 gene within the sst1 locus (Pan et al., 2005). 
Despite excessive cell death in the lung, Card9/ BMDMs 
were equally prone to apoptosis as their WT counterparts in 
contrast to the sst1-susceptible macrophages (Pan et al., 2005), 
suggesting that CARD9 is not directly involved in apoptosis 
control. In infected Card9/ mice, increased apoptosis in 
lungs was not compensated by cellular replacement, similar 
to some extent to mice deficient in the IL-1–MyD88 path-
way (Fremond et al., 2004, 2007).
Deficient IL-1 signaling accounts for most of the MyD88 
KO phenotype because of a shared signaling pathway (Fremond 
et al., 2007). CARD9 does not share any molecules involved 
in signal transduction with either IL-1R or the MyD88 adap-
tor, but regulates IL-1 release at APC level. Its propensity to 
regulate inflammasome function was recently revealed during 
fungal infection (Gross et al., 2009). Accordingly, we exclude 
a major impact of MyD88 on CARD9 signaling. Instead, we 
consider more likely a regulatory loop via modulation of 
IL-1 release by CARD9 signaling. Consistent with our 
assumptions,  sensing  of  MTB  by  dectin-1  and  NOD2  is 
MyD88-independent. Our in vitro data point to a syk depen-
dency of dectin-1 signaling, whereas NOD2 signaling involves 
stable ubiquitination of RIP2 (Yang et al., 2007). Card9/ 
mice up-regulated iNOS in inflamed lungs and Card9/ 
BMDMs controlled MTB growth in vitro and produced NO 
similar  to  WT  cells.  Moreover,  LRG-47  expression  after 
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in infected tissue sites. Recent studies revealed that granulo-
poietic emergency program depends on IL-1R signaling and 
that low IL-1 levels could induce late neutrophilic responses 
(Ueda et al., 2009). Although we did not detect significant 
in vivo IL-1 differences between the CARD9 KO mutants 
and congenic controls during TB, the potential role of the 
CARD9 adaptor in hematopoetic stem cell and progenitor 
proliferation remains to be established. Card9 deficiency re-
duces nuclear translocation of NF-B (Gross et al., 2006), 
and KC comprises NF-B–binding sites in its promoter 
(De Filippo et al., 2008). Reduced proinflammatory cytokine 
responses in MTB-infected macrophages in vitro support de-
regulated KC synthesis. Diminished IL-6 production could di-
rectly impair KC abundance because gp130-dependent STAT-3 
signaling negatively regulates KC responses and PMN clear-
ance (Fielding et al., 2008). Whether lung PMN kinetics is 
directly affected or whether the emergency granulopoietic 
program is distorted remains to be clarified. Beneficial effects 
of PMN depletion or G-CSF neutralization support patho-
logical functions of the granulocytes during acute TB in the 
absence of CARD9. Importantly, previous studies on tran-
sient PMN depletion by anti–Gr-1 mAb in WT mice (Seiler 
et al., 2000; Keller et al., 2006) did not observe major effects 
on TB, as seen here for CARD9 KO mutants (Fig. 7 A). 
Although inflammatory monocytes are Gr-1+ (Geissmann et al., 
2003) and mAb treatment could have affected this popula-
tion, available data rule out a major involvement of these cells 
in TB. Mice deleted in CCL2 (Kipnis et al., 2003) or CCR2 
(Scott and Flynn, 2002), which are required for tissue recruit-
ment or egress from BM of inflammatory monocytes, respec-
tively, controlled MTB infection efficiently. We conclude that 
exacerbated lung neutrophilic inflammation represents a hall-
mark of lung pathology in MTB-infected Card9/ mice. 
Although PMN depletion reduced inflammation and prolonged 
survival, it did not considerably impact on bacterial burdens in 
lung, suggesting that inflammation alone triggered lethality. 
However, reduction of MTB loads by drug treatment during 
polarized PMN inflammation rescued Card9/ mice from le-
thal outcome.
The role of neutrophils in TB remains controversial 
(Seiler et al., 2000; Eruslanov et al., 2005; Keller et al., 2006). 
Our data reveal that PMN abundantly transcribe CARD9, 
yet reveal a detrimental role of granulocytes in TB. Our ob-
servation is consistent with a recent study describing a previ-
ously unknown role of PMN in dampening inflammation via 
IL-10 (Zhang et al., 2009). We demonstrate that CARD9 is 
essential for IL-10 synthesis in MTB-infected PMN. Absent 
IL-10 in CARD9 KO animals abrogated negative feedback 
regulation of various cytokine and chemokine genes. Control 
by both MyD88 and CARD9 of IL-10 production in PMN 
during TB could explain the similar pathology of MTB-
infected KO mice deficient in CARD9 or MyD88. Neutro-
philic inflammation of the lung is followed by defective 
removal of apoptotic cells, termed efferocytosis. Studies on 
chronic lung inflammation emphasize an important role of early 
efferocytosis  for  maintenance  of  biological  lung  functions 
absence of CARD9, innate inflammation cannot be controlled 
although apparently adequate T cell responses can develop.
MTB recognition by different TLRs (Quesniaux et al., 
2004; Schnappinger et al., 2006) and NOD2 (Ferwerda et al., 
2005; Gandotra et al., 2007; Yang et al., 2007) is well estab-
lished. Moreover, evidence for a role of CLRs in MTB sens-
ing has been obtained (Yadav and Schorey, 2006; Rothfuchs 
et al., 2007). The complexity of the MTB cell wall requires 
combinatorial recognition and engagement of different types 
of PRRs, as emphasized by our experiments. Further, our 
data establish a critical involvement of CARD9 signaling in 
cytokine secretion by BMDMs in response to MTB and evi-
dence that MTB sensed by dectin-1 and NOD2 uses CARD9 
as an adaptor molecule. Involvement of other ITAM-based 
molecules that signal via CARD9, including Mincle, a CLR 
member recently proposed to sense mycobacterial TDM 
(Ishikawa et al., 2009), cannot be excluded. Convergence of 
multiple PRR pathways on the CARD9 adaptor minimizes 
metabolic expenses for the host. On the other hand, conver-
gence increases host vulnerability. Consistent with recent gene 
expression profiling results, demonstrating that CARD9 is mod-
ulated in human DCs early after MTB infection (Tailleux 
et al., 2008), our data emphasize the need to clarify whether 
polymorphisms in CARD9 influence susceptibility to MTB 
in humans. Recent genetic analysis extended the link between 
fungi detection and CARD9 signaling from the mouse to the 
human system. Homozygous CARD9 mutation was found 
to predispose humans to chronic mucocutaneous candidiasis 
(Glocker et al., 2009). Based on our observations in TB-infected 
naive and BCG-vaccinated Card9/ mice, and because of 
the fact that in TB-endemic regions vaccination programs 
are in place, genetic screening for an association between 
CARD9 polymorphisms and susceptibility to TB is challeng-
ing but necessary.
Lung damage in Card9/ mice was governed by aug-
mented granulopoiesis, neutrophilic inflammation, and apop-
totic cell death which progressed to secondary necrosis. 
Pathology was correlated with local production of G-CSF, 
KC, and MCP-1 and systemic release of G-CSF. These cyto-
kines are produced by myeloid, endothelial, and epithelial cells 
and stimulate granulopoiesis and attract granulocytes to tissue 
sites. G-CSF is induced by various cytokines and bacterial 
products and stimulates differentiation, maturation, and func-
tional activation of neutrophilic granulocytes. Evidence is ac-
cumulating that acute mobilization of PMNs from the BM is 
induced by simultaneous release and action of G-CSF and 
KC (Wengner et al., 2008). This cytokine millieu occurred in 
TB-infected mice in absence of CARD9 and induced both 
release of granulocytes into the periphery and their acceler-
ated recruitment to the lung. Transcriptional regulation of 
KC was augmented early after infection and paralleled PMN-
specific  transcripts.  Neutrophil-specific  genes  are  actively 
transcribed during differentiation in BM under steady-state 
conditions (Borregaard et al., 2007). However, during infec-
tious stress and high neutrophil demand immature granulo-
cytes are released, and hence PMN transcripts can be detected JEM VOL. 207, April 12, 2010 
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BCG  vaccination  and  DTH.  Mice  were  s.c.  inoculated  with  106  
CFUs BCG Danish 1331 (SSI). At 3 wk after vaccination, BCG-vaccinated 
and control mice were i.d. challenged with 2 µg PPD into the footpad 
(SSI). Foot pad swelling was recorded 48 h after challenge using a dial 
gauge caliper.
BM chimera generation and infection. WT and Card9/ mice at 8 wk 
of age were maintained on antibiotics (0.1 mg/ml Ciprofloxacin and 2 mg/
ml Neomicin) 1 wk before irradiation. Irradiation was performed using a 
dose of 4 Gy, and animals were further kept for 4 wk on antibiotics in drink-
ing water. After withdrawal of antibiotics, complete repopulation of the or-
gans with immune cells was allowed for another 4 wk, and, subsequently, 
leukocytes were PCR typed to control efficacy of reconstitution. MTB 
aerosol infection was performed (as described in the Mice and MTB infec-
tion section) at 10 wk after sublethal whole-body irradiation and complete 
reconstitution with donor leukocytes.
Primary cell cultures and innate immunity assays. BMDMs and BM-
DCs were obtained from tibia and femur bones and maintained in Dulbecco’s 
Modified Eagle Medium containing 20% L929-cell supernatant, 10% heat-
inactivated FCS, 5% heat-inactivated HS, 2 mM glutamine or RPMI supple-
mented with 10% heat-inactivated FCS and 200 U/ml recombinant mouse 
GM-CSF, respectively. Differentiated resting cells and cells pretreated with 
recombinant mouse IFN- (100 U/ml; Strathmann Biotech AG) were in-
fected with MTB H37Rv at MOI 5 or treated with MTB-derived com-
pounds. MTB-derived compounds were solubilized in PBS unless otherwise 
stated. PG and mAGP were sonified for better solubilization. TDM solution 
was  prepared  by  repeatedly  warming  the  solution  in  PBS  containing  2% 
DMSO at 50°C, followed by repeated vortexing. PMN were isolated from 
BM as previously described (Allport et al., 2002). For in vitro infection experi-
ments, MTB was grown in Middlebrook 7H9 broth (BD) supplemented with 
0.05% glycerol and Tween 80, and 10% ADC enrichment (BD) to an early log 
phase and washed with PBS, and single bacteria were resuspended in culture 
media at desired concentrations. After a 4-h incubation, noninternalized bac-
teria were washed away and incubation continued as indicated in the results. 
For blocking experiments, we used laminarin (500 µg/ml) and piceatanol 
(1–10 µM). MTB was heat inactivated at 80°C for 40 min. Bacterial growth 
was assessed by [3H]Uracil incorporation (Flesch and Kaufmann, 1987). Con-
centration of TNF, IL-6, CCL5, IL-10, and IL-12p40 in cell culture superna-
tants was determined 24 h p.i. or after stimulation using commercial ELISA 
kits (R&D Systems). Apoptotic rates were measured using Cell Death Plus 
Detection kit ELISA (Roche) according to the manufacturer’s instructions. 
Nitric oxide was determined using the Griess reagent (Sigma-Aldrich).
Multiplex cytokine assays. Sera and lung homogenates from MTB- 
infected mice were assayed for cytokine and chemokine levels using multiplex 
bead-based immunoassay kits (Bio-Plex Cytokine Assay; Bio-Rad Laborato-
ries) according to manufacturer’s instructions.
Quantitative RT-PCR. Lung tissue or, alternatively, cell pellets were ho-
mogenized in Trizol and mRNA was extracted using acidic phenol chloroform 
extraction. RNA integrity and the absolute amount of total RNA were verified 
with a Bioanalyzer 2100 (Agilent Technologies). Expression levels of Cxcl1, 
Ngp, Mpo, Ctsg, Irgm1, LRG-47, Card9, and housekeeping gene GAPDH 
were analyzed using QuantiTect primer-probes (QIAGEN). Fold changes were 
calculated with the CT method using uninfected samples as calibrator for 
tissue analysis or normalized to GAPDH with the equation 1.8(GAPDH-CARD9) × 
(1,000,000) to evaluate CARD9 expression in different cell types.
MPO  concentration. Enzyme levels in sera from MTB-infected mice 
were determined using a commercial ELISA, according to manufacturer’s 
instructions (Hycult Biotechnology).
Histology and immunohistochemistry. Organs were fixed with 4% wt/
vol PFA for 24 h and embedded in paraffin. Sections (2 µm) were Giemsa 
stained. Mycobacteria in the lungs were visualized by acid-fast staining 
(Vandivier et al., 2002). Moreover, a detrimental role of so-
called “frustrated” PMN, unable to meet the pathogen in 
inflamed tissue, has been described (Nathan, 1987). In MTB-
infected Card9/ mice, collateral damage during secondary 
necrosis and systemic release of MPO became life threaten-
ing. Neutrophils undergoing necrosis leak enzymes and noxious 
agents that damage the surrounding tissue without contribut-
ing to MTB control. Notably, granulocyte-derived MPO causes 
cytotoxicity in alveolar macrophages (Grattendick et al., 2002). 
Increased levels of circulating MPO were recently reported 
in patients with active lung TB (Koziol-Montewka et al., 2004). 
As a corollary, we assume absence of a regulatory loop via 
lack of IL-10 and a circulus vitiosus with granulocytes initiat-
ing inflammation and ineffective efferocytosis boosting in-
flammatory responses. Collectively, we conclude that both 
fine-tuning of acute PMN inflammation and control of MTB 
replication in lung tissue are responsible for lethal TB in ab-
sence of CARD9 signaling. The molecular mechanisms un-
derlying unleashed bacterial growth remain to be deciphered. 
Susceptibility is apparently independent from control by the 
acquired T cell response and can be overcome by vaccination. 
Thus, the key adaptor CARD9 plays an essential role in au-
tonomous orchestration of innate immunity in TB.
MATERIALS AND METHODS
Antibodies and chemical reagents. The following polyclonal antibodies 
were used for immunostainings: MPO (Abcam), iNOS (LabVision), and goat 
anti–rabbit (Dianova). We used the following mAb for flow cytometric in-
vestigations: CD4 (RM4-5), IFN- (XMG-1.2), IL-2 (JES6-5H4), Ly6G/C 
(RB6-8C5), CD11b (M1/70; eBioscience), CD8 (YTS169), TNF (XT22), 
CD3 (145-2C11), CD28 (37.51), CD62L (MEL-14), CD25 (PC61), CD16/
CD32 (2.4G2), F4/80 (CI:A3-1), and CD11c (N418; antibodies purified 
from hybridoma supernatants; American Type Culture Collection), IL-17 
(TC11-18H10; BD Biosciences). PG, mAGP, AG, MAME, and manLam 
were derived from MTB (Colorado State University). LPS and zymosan 
were obtained from Invivogen; piceatannol and lovastatin were obtained from 
Calbiochem; TDM, cytochalasin, and laminarin were obtained from Sigma-
Aldrich. DNaseI and collagenase D were obtained from Roche. CD11c 
beads were used for selection of differentiated BMDCs (Miltenyi Biotec).
Mice and MTB infection. WT (C57BL/6) and Card9/ mice (Gross et al., 
2006) were bred at III. Medizinische Klinik, Klinikum rechts der Isar, Tech-
nische Universität München, Germany. The Card9/ mouse strain was 
backcrossed onto the genetic background of C57BL/6 for more than six 
generations. Mice were 8–12 wk of age at the beginning of the experiments, 
matched for age and sex, and kept under specific pathogen-free (SPF) condi-
tions at the Max Planck Institute for Infection Biology in Berlin, Germany. 
Infection of mice was performed using a Glas-Col inhalation exposure sys-
tem. The initial challenge dose was verified 24 h p.i. by plating complete lung 
homogenates onto Middlebrook 7H11 agar plates. At different time points, 
bacterial burdens were assessed by mechanical disruption of the organs in 
water/1% wt/vol BSA/1% vol/vol Tween 80 (WTA), and plating serial di-
lutions onto Middlebrook 7H11 agar plates. After 3 wk, MTB colonies were 
counted. For PMN depletion, mice were treated i.p. with anti-Gr-1 anti-
bodies (Rb6-8C5) in PBS 200 µg/mouse/shot or with control rat IgG at days 
8, 11, and 14 p.i. G-CSF neutralization was achieved by i.p. injection of 100 µg/
mouse/shot anti–mouse G-CSF (R&D Systems) at days 10 and 14 p.i. Mice 
were treated with first-line TB drugs INH (0.1 g/liter) and RIF (0.1 g/liter; 
Fluka) in drinking water for 6 wk. Antibiotic treatment started at different 
time points p.i., as indicated in text or figure legend. Animal protocols were 
approved by Landesamt für Gesundheit und Soziales, Berlin, Germany.790 CARD9 in control of mycobacterial infection | Dorhoi et al.
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we performed surface staining for CD8, CD4, and intracellular staining for 
the following cytokines: TNF, IL-17, IL-2, and IFN-. Cells were analyzed 
using a FACSCanto II flow cytometer and FACSDiva software (BD).
PMN isolation from buffy coats and PMN uptake assay. PMN were iso-
lated from buffy coats using the reversal method. Ficoll gradient separation was 
followed by Dextran sedimentation and osmotic lysis of remaining erythrocytes. 
Overnight apoptotic PMNs were co-cultured with BMDMs at a ratio 5:1 for 
1 h. BMDM monolayers were washed extensively with PBS and fixed with 
2.5% glutaraldehyde. Internalized apoptotic PMNs were visualized by adding 
MPO substrate o-dianisidine (Sigma-Aldrich) and microscopic examination.
GFP bacteria uptake. GFP-expressing BCG microorganisms were grown 
in Middlebrook 7H9 broth supplemented with glycerol and 0.05% Tween 
80, and 10% ADC enrichment medium to an early log phase, washed in 
PBS, and single bacteria were resuspended in culture media at desired con-
centrations. Differentiated BMDMs and BMDCs were incubated at different 
MOI with fluorescent bacteria for 2 h. Cells were washed extensively with 
PBS, detached and stained for specific cell markers. APCs were analyzed us-
ing a FACSCanto flow cytometer and FACSDiva software.
Statistical  analysis.  PRISM  GraphPad  software  was  used  for  statistical 
analysis. Bacterial titers were analyzed by the Mann-Whitney test, survival 
was assessed by Kaplan-Meier curves and log-rank test. Frequencies and 
numbers of APC, cytokine-positive T cells, concentrations of cytokines and 
chemokines were compared using a two-way ANOVA followed by Bonfer-
oni’s post-test. In vitro cytokine levels were compared using t-student test. 
Only P values ≤ 0.05 were considered statistically significant.
Online supplemental material. Fig. S1 shows that Card9/ mice gradu-
ally lost body weight during acute TB infection. Fig. S2 depicts spleen pa-
thology and indicates that despite increased susceptibility to TB, Card9/ 
mice had serum NO levels comparable to WT controls. Fig. S3 shows apop-
totic PMN clearance capacities of Card9/ and WT macrophages. Fig. S4 
indicates  impaired  cytokine  production  in  MTB-infected  BMDCs  from 
Card9/ mice. Fig. S5 shows that laminarin treatment did not interfere with 
mycobacterial uptake and indicates that Card9/ BMDMs and DCs were 
impaired in mAGP detection. Fig. S6 shows that Card9/ mice mounted 
apparently intact T cell responses after TB challenge. Fig. S7 indicates that 
PMN depletion did not impact on bacterial burdens, but improved clinical 
disease. Fig. S8 shows that Card9/ mice were not impaired in LRG-47 
regulation in the lung during TB infection. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20090067/DC1.JEM VOL. 207, April 12, 2010 
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